Helixis Corporate Logo

Innovations in PCR Testing
The Helixis Team
News & Events at Helixis
Opportunities at Helixis
The Helixis Community
Contact Us at Helixis


Helixis HomeHelixis Site MapContact Helixis



May 19, 2008

Helixis, Inc. Expands Management Team

Carlsbad, Calif., May 19, 2008 - Helixis, Inc., an early-stage company focused on optimizing access to molecular analysis tools in research and clinical diagnostics, today announced the addition of three experienced marketing and development executives to its management team. Judy Macemon has been named vice president, marketing; Adrian Fawcett, senior director, engineering; and Sameer Deepak Rohatgi, senior director, business development.

"Judy, Adrian, and Sameer will play critical roles at Helixis, particularly as we complete development and begin commercialization of our first research instrument," said Alex Dickinson, president, chief executive officer and co-founder, Helixis, Inc. "Our ability to attract this caliber of talent reflects both the rapid progress we've made to date and the promise of our vision for the evolution of real-time PCR."

Judy Macemon has an extensive track record as a senior executive responsible for strategic marketing and product commercialization in life science research and clinical diagnostics companies. Her previous experience includes national and global business and marketing positions at Invitrogen, Stratagene (acquired by Agilent), Agilent, Accelerys, Chromagen, Becton Dickinson and Company, and MicroProbe Corporation. At Stratagene, Ms. Macemon led the launch and commercialization of the company's real-time PCR instrument portfolio. She also served as director of technical services for the Diagnostics Division of Baxter Healthcare and managed the clinical laboratory for Group Health Cooperative in Seattle. Ms. Macemon began her career working in hospital, clinical reference and academic research laboratories. She earned a BS degree in medical technology from Louisiana State University, an MS in clinical microbiology from Texas Women's University, and an MBA from San Diego State University.

Adrian Fawcett has 20 years of product development experience in scientific instruments and systems. Over nearly a decade at Applied BioSystems, most recently as director of R&D, Singapore Operations, Mr. Fawcett led multiple development teams and worked extensively with next-generation real-time PCR systems and related technologies. Earlier, he held R&D management positions with PEBiosciences and Perkin-Elmer, where he focused on development of nucleic acid analysis tools. Mr. Fawcett holds a Physics BSc (Hons) degree from Lancaster University, UK.

Sameer Deepak Rohatgi brings significant experience in global marketing, business development, and commercialization of life science tools and molecular diagnostics to Helixis. He held several positions in the Life Science and Chemical Analysis division of Agilent Technologies, including strategic planning for the $1.9 billion business. Most recently, he served as Associate Director, Genomics Marketing where he led the commercial introduction of novel genetic and epigenetic microarray assays that achieved over 20% year over year growth. Earlier, he filled strategic marketing and project management roles at Incyte. He began his career as a management consultant with Ernst & Young LLP. Mr. Rohatgi earned a BSE in biomedical engineering from Duke University, an MS in biomedical engineering from Case Western Reserve University, and an MBA from the George L. Graziadio School at Pepperdine University.

About Helixis, Inc.
Helixis, Inc., with headquarters in Carlsbad, CA, is a privately-held developer of innovative nucleic acid analysis tools for research and clinical diagnostics. The Company was founded in 2007 by a unique collaboration between molecular biologists and engineers to pursue technologies discovered in the labs of Nobel Laureate David Baltimore, PhD, and Axel Scherer, PhD, at the California Institute of Technology. Helixis is currently focused on delivering a new generation of high-performance, compact, easy-to-use, and low-cost "personal" real-time polymerase chain reaction (qPCR) systems to the life science research community. More information about Helixis is available at www.helixis.com.